Zivo Bioscience
(OTC) ZIVO
Zivo Bioscience Financials at a Glance
Market Cap
$36.16M
Revenue (TTM)
$209.03K
Net Income (TTM)
$8.49M
EPS (TTM)
$-2.27
P/E Ratio
-4.10
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$9.22
Volume
100
Open
$9.22
Price
$9.22
Volume
100
Open
$9.22
Previous Close
$9.30
Daily Range
$9.22 - $9.22
52-Week Range
$6.95 - $20.00
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$9.22
Volume
100
Open
$9.22
Previous Close
$9.30
Daily Range
$9.22 - $9.22
52-Week Range
$6.95 - $20.00
ZIVO News
ZIVO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zivo Bioscience
Industry
Personal Products
Sector
Consumer StaplesEmployees
7
CEO
John Bernard Payne, MBA
Website
www.zivobioscience.comHeadquarters
Bloomfield Hills, MI 48304, US
ZIVO Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-40%
Net Income Margin
-41%
Return on Equity
0%
Return on Capital
3%
Return on Assets
-15%
Earnings Yield
-24.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$36.16M
Shares Outstanding
3.89M
Volume
100
Short Interest
0.00%
Avg. Volume
779.869
Financials (TTM)
Gross Profit
$48.95K
Operating Income
$13.36M
EBITDA
$13.36M
Operating Cash Flow
$4.31M
Capital Expenditure
$0.00
Free Cash Flow
$4.31M
Cash & ST Invst.
$1.54M
Total Debt
$254.36K
Zivo Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$65.63K
+108.3%
Gross Profit
$21.29K
+125.3%
Gross Margin
32.44%
N/A
Market Cap
$36.16M
N/A
Market Cap/Employee
$5.17M
N/A
Employees
7
N/A
Net Income
$1.03M
+54.5%
EBITDA
$1.02M
+54.9%
Quarterly Fundamentals
Net Cash
$762.47K
-250.3%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$231.79K
N/A
Short Term Debt
$587.91K
+55.9%
Return on Assets
-15.17%
N/A
Return on Invested Capital
2.77%
N/A
Free Cash Flow
$266.56K
+75.4%
Operating Cash Flow
$266.56K
+75.4%